SELP and cancer: Of all the biomarkers analyzed among cancer-plus-stroke participants, it was noted that only D-dimer, p-selectin, sICAM-1, sVCAM-1 and microemboli were associated with the primary outcome (composite of major thromboembolic events or death), whereas thrombin-antithrombin and TM were not.